Research progress on animal models of nonalcoholic steatohepatitis
Author:
Affiliation:

1.College of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, China. 2. Laboratory Animal Research Center/ Comparative Medical Research Institute, Zhejiang Chinese Medical University, Hangzhou 310053

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    With the increasing global prevalence of metabolic syndrome, the prevalence of non-alcoholic fatty liver disease (NAFLD) has also risen sharply. NAFLD is the most common chronic liver disease in the world and includes simple steatosis and non-alcoholic fatty hepatitis ( NASH), advanced fibrosis, cirrhosis and hepatocellular carcinoma. NASH is an important stage from simple steatosis to fibrosis, cirrhosis and liver cancer. Therefore, the prevention and treatment of NASH has become an important research focus. Animal models are critical tools for studying the pathogenesis of diseases, research and development of therapeutic drugs, and formulating prevention and treatment strategies. The animal models that have been developed so far for NASH mainly simulate the pathological morphology and clinical characteristics of human NASH. These models include dietary animal models, drug-induced animal models and genetically modified animal models, and each model has its own advantages and disadvantages. In this paper, we review the research and applications of NASH animal models for NASH research.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 30,2020
  • Revised:
  • Adopted:
  • Online: March 23,2021
  • Published: